Julia Carrier, Ph.D.
VP, Nonclinical
REGULATORY AFFAIRS PRACTICE
Dr. Julia Carrier joined Eliquent in 2016 following a distinguished career of 20 years of experience in nonclinical studies. At Eliquent she leads an all-PhD team to provide a comprehensive panel of services including nonclinical program strategy and study design, preparation of regulatory meetings and IND/NDA/BLA regulatory filing. She has led multiple FDA meetings and discussions surrounding regulatory pharmacology, pharmacokinetic, and toxicology for chemical and protein drugs as well as cell gene therapies.
Fluent in both English and Mandarin, Dr. Carrier is an experienced project manager (a certified PMP) and has led teams in drug development or business operations in multi-cultural, global working environments. Dr. Carrier is an accomplished scientist with broad knowledge in drug discovery and has hands-on experience in nonclinical programs from pre-exploratory to IND/BLA/NDA filing and post-approval research. She has written high-quality publications in the areas of autoimmunity, inflammation, and neurodegenerative diseases and published in Nature. Dr. Carrier is a detail-oriented team player with strong work ethics, and excellent organizational and interpersonal communication skills.
During Dr. Carrier’s time at Pfizer, she worked on autoimmune and inflammatory drug development and nonclinical studies. Her responsibility included leading or supporting multiple projects of monoclonal antibodies or proteins targeting adaptive and innate immunity, with an emphasis on novel cytokine/chemokine, co-stimulation pathways, and biomarker identification. She designed and conducted nonclinical studies, authorized study reports and IND documents, and managed projects.
EDUCATION & CERTIFICATIONS
- Ph.D. in Immunology and Molecular Pathogenesis, Emory University
- Bachelor of Science in Medicinal Chemistry, Peking University
- Certified Project Management Professional (PMP), Project Management Institute